Eisai to Unveil New Lecanemab Clinical and Real-World Data at AAIC 2026
Eisai will present a wide-ranging set of clinical and real-world evidence for the Alzheimer’s drug lecanemab at the Alzheimer’s Association International Conference in London this July. The presentations, spanning July 12 to 15, will focus on subcutaneous delivery, long-term maintenance dosing, and outcomes across diverse patient populations.



























